284 related articles for article (PubMed ID: 26368010)
1. Associations between maternal serum free beta human chorionic gonadotropin (β-hCG) levels and adverse pregnancy outcomes.
Sirikunalai P; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Tongsong T
J Obstet Gynaecol; 2016; 36(2):178-82. PubMed ID: 26368010
[TBL] [Abstract][Full Text] [Related]
2. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
Spencer K
Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
[TBL] [Abstract][Full Text] [Related]
3. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
Spencer K; Yu CK; Cowans NJ; Otigbah C; Nicolaides KH
Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443
[TBL] [Abstract][Full Text] [Related]
4. Maternal first trimester serum levels of free-beta human chorionic gonadotrophin and male genital anomalies.
Schneuer FJ; Bower C; Holland AJ; Tasevski V; Jamieson SE; Barker A; Lee L; Majzoub JA; Nassar N
Hum Reprod; 2016 Aug; 31(8):1895-903. PubMed ID: 27496947
[TBL] [Abstract][Full Text] [Related]
5. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
[TBL] [Abstract][Full Text] [Related]
6. [Relationship of adverse pregnancy outcomes and a high risk serum screen for Down syndrome in the second trimester].
Hu XY; Bian XM; Jiang YL; Liu SY
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):427-30. PubMed ID: 22932108
[TBL] [Abstract][Full Text] [Related]
7. Elevated second-trimester free beta-hCG as an isolated finding and pregnancy outcomes.
Brajenović-Milić B; Tislarić D; Zuvić-Butorac M; Bacić J; Petrović O; Ristić S; Mimica M; Kapović M
Fetal Diagn Ther; 2004; 19(6):483-7. PubMed ID: 15539871
[TBL] [Abstract][Full Text] [Related]
8. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).
Dugoff L; Hobbins JC; Malone FD; Porter TF; Luthy D; Comstock CH; Hankins G; Berkowitz RL; Merkatz I; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Vidaver J; D'Alton ME
Am J Obstet Gynecol; 2004 Oct; 191(4):1446-51. PubMed ID: 15507981
[TBL] [Abstract][Full Text] [Related]
9. First trimester predictors of adverse pregnancy outcomes.
Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
[TBL] [Abstract][Full Text] [Related]
10. Elevated maternal serum-free β-human chorionic gonadotropin (β-hCG) and reduced risk of spontaneous preterm delivery
Soni S; Krantz DA; Blitz MJ; Vohra N; Rochelson B
J Matern Fetal Neonatal Med; 2019 Oct; 32(19):3191-3196. PubMed ID: 29642747
[No Abstract] [Full Text] [Related]
11. The impact of assisted reproductive technology on the association between first-trimester pregnancy-associated plasma protein a and human chorionic gonadotropin and adverse pregnancy outcomes.
Zhong Y; Bradshaw R; Stanley AP; Odibo AO
Am J Perinatol; 2011 May; 28(5):347-54. PubMed ID: 21082535
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum levels of free beta-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery.
Morssink LP; Kornman LH; Hallahan TW; Kloosterman MD; Beekhuis JR; de Wolf BT; Mantingh A
Prenat Diagn; 1998 Feb; 18(2):147-52. PubMed ID: 9516016
[TBL] [Abstract][Full Text] [Related]
13. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes.
Krantz D; Goetzl L; Simpson JL; Thom E; Zachary J; Hallahan TW; Silver R; Pergament E; Platt LD; Filkins K; Johnson A; Mahoney M; Hogge WA; Wilson RD; Mohide P; Hershey D; Wapner R;
Am J Obstet Gynecol; 2004 Oct; 191(4):1452-8. PubMed ID: 15507982
[TBL] [Abstract][Full Text] [Related]
14. Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption.
Ranta JK; Raatikainen K; Romppanen J; Pulkki K; Heinonen S
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):48-52. PubMed ID: 21482016
[TBL] [Abstract][Full Text] [Related]
15. First trimester maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A in pregnancies complicated by diabetes mellitus.
Savvidou MD; Syngelaki A; Muhaisen M; Emelyanenko E; Nicolaides KH
BJOG; 2012 Mar; 119(4):410-6. PubMed ID: 22324916
[TBL] [Abstract][Full Text] [Related]
16. Prediction of adverse perinatal outcome by maternal serum screening for Down syndrome in an Asian population.
Hsieh TT; Hung TH; Hsu JJ; Shau WY; Su CW; Hsieh FJ
Obstet Gynecol; 1997 Jun; 89(6):937-40. PubMed ID: 9170469
[TBL] [Abstract][Full Text] [Related]
17. Association between isolated abnormal levels of maternal serum unconjugated estriol in the second trimester and adverse pregnancy outcomes.
Settiyanan T; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Tongsong T
J Matern Fetal Neonatal Med; 2016; 29(13):2093-7. PubMed ID: 27480207
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Serum
Huang J; Liu Y; Yang H; Xu Y; Lv W
Comput Math Methods Med; 2022; 2022():8315519. PubMed ID: 36118828
[TBL] [Abstract][Full Text] [Related]
19. Association between birth weight and first-trimester free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A.
Canini S; Prefumo F; Pastorino D; Crocetti L; Afflitto CG; Venturini PL; De Biasio P
Fertil Steril; 2008 Jan; 89(1):174-8. PubMed ID: 17509577
[TBL] [Abstract][Full Text] [Related]
20. Elevated maternal mid-trimester chorionic gonadotropin > or =4 MoM is associated with fetal cerebral blood flow redistribution.
Hershkovitz R; Erez O; Sheiner E; Landau D; Mankuta D; Mazor M
Acta Obstet Gynecol Scand; 2003 Jan; 82(1):22-7. PubMed ID: 12580835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
